Research ArticleAccepted Article
Open Access
Nail Psoriasis: Diagnosis, Assessment, Treatment Options, and Unmet Clinical Needs
Gurjit S. Kaeley, Lihi Eder, Sibel Zehra Aydin, Phoebe Rich and Catherine J. Bakewell
The Journal of Rheumatology February 2021, jrheum.201471; DOI: https://doi.org/10.3899/jrheum.201471
Gurjit S. Kaeley
Department of Medicine, University of Florida College of Medicine, Division of Rheumatology, 653–1 West 8th St, LRC 2nd Floor L-14, Jacksonville, Florida 32209- 6561, USA; University of Toronto, Women's College Research Institute, 76 Grenville Street Toronto, ON M5S 1B2, Canada; University of Ottawa, Faculty of Medicine, 1967 Riverside Drive, Ottawa, ON, K1H 7W9, Canada; Oregon Dermatology & Research Center, 2565 NW Lovejoy St # 200, Portland, OR 97210, USA; Salt Lake Clinic, 389 South 900 East, Salt Lake City, UT 84103, USA. This study is funded by Novartis Pharmaceuticals Corporation, East Hanover, NJ. G. S. Kaeley has received consultancy fees from Novartis Pharmaceuticals Corporation. L. Eder received research and educational grants or consultancy fees from AbbVie, Amgen, Pfizer, Janssen, Eli Lily, Novartis, and Celgene. S. Z. Aydin has received consultancy fees from AbbVie, Celgene, Eli Lily, Janssen, Novartis Pharmaceuticals Corporation Pfizer, and UCB. P. Rich has received research funding from AbbVie, Bristol-Myers-Squibb, Cellceutix (now Innovation Pharmaceuticals), Eli Lilly, Kadmon Holdings, Sun Pharma/Merck, and UCB. C. Bakewell has received consultancy fees from and/or served on speakers bureaus for AbbVie, Novartis Pharmaceuticals Corporation, Pfizer, and Sanofi Genzyme/Regeneron. Address Correspondence to: Gurjit S. Kaeley, University of Florida College of Medicine, Division of Rheumatology, 653–1 West 8th St, LRC 2nd Floor L-14, Jacksonville, Florida 32209-6561, USA; E-mail: Gurjit.Kaeley@jax.ufl.edu
Lihi Eder
Department of Medicine, University of Florida College of Medicine, Division of Rheumatology, 653–1 West 8th St, LRC 2nd Floor L-14, Jacksonville, Florida 32209- 6561, USA; University of Toronto, Women's College Research Institute, 76 Grenville Street Toronto, ON M5S 1B2, Canada; University of Ottawa, Faculty of Medicine, 1967 Riverside Drive, Ottawa, ON, K1H 7W9, Canada; Oregon Dermatology & Research Center, 2565 NW Lovejoy St # 200, Portland, OR 97210, USA; Salt Lake Clinic, 389 South 900 East, Salt Lake City, UT 84103, USA. This study is funded by Novartis Pharmaceuticals Corporation, East Hanover, NJ. G. S. Kaeley has received consultancy fees from Novartis Pharmaceuticals Corporation. L. Eder received research and educational grants or consultancy fees from AbbVie, Amgen, Pfizer, Janssen, Eli Lily, Novartis, and Celgene. S. Z. Aydin has received consultancy fees from AbbVie, Celgene, Eli Lily, Janssen, Novartis Pharmaceuticals Corporation Pfizer, and UCB. P. Rich has received research funding from AbbVie, Bristol-Myers-Squibb, Cellceutix (now Innovation Pharmaceuticals), Eli Lilly, Kadmon Holdings, Sun Pharma/Merck, and UCB. C. Bakewell has received consultancy fees from and/or served on speakers bureaus for AbbVie, Novartis Pharmaceuticals Corporation, Pfizer, and Sanofi Genzyme/Regeneron. Address Correspondence to: Gurjit S. Kaeley, University of Florida College of Medicine, Division of Rheumatology, 653–1 West 8th St, LRC 2nd Floor L-14, Jacksonville, Florida 32209-6561, USA; E-mail: Gurjit.Kaeley@jax.ufl.edu
Sibel Zehra Aydin
Department of Medicine, University of Florida College of Medicine, Division of Rheumatology, 653–1 West 8th St, LRC 2nd Floor L-14, Jacksonville, Florida 32209- 6561, USA; University of Toronto, Women's College Research Institute, 76 Grenville Street Toronto, ON M5S 1B2, Canada; University of Ottawa, Faculty of Medicine, 1967 Riverside Drive, Ottawa, ON, K1H 7W9, Canada; Oregon Dermatology & Research Center, 2565 NW Lovejoy St # 200, Portland, OR 97210, USA; Salt Lake Clinic, 389 South 900 East, Salt Lake City, UT 84103, USA. This study is funded by Novartis Pharmaceuticals Corporation, East Hanover, NJ. G. S. Kaeley has received consultancy fees from Novartis Pharmaceuticals Corporation. L. Eder received research and educational grants or consultancy fees from AbbVie, Amgen, Pfizer, Janssen, Eli Lily, Novartis, and Celgene. S. Z. Aydin has received consultancy fees from AbbVie, Celgene, Eli Lily, Janssen, Novartis Pharmaceuticals Corporation Pfizer, and UCB. P. Rich has received research funding from AbbVie, Bristol-Myers-Squibb, Cellceutix (now Innovation Pharmaceuticals), Eli Lilly, Kadmon Holdings, Sun Pharma/Merck, and UCB. C. Bakewell has received consultancy fees from and/or served on speakers bureaus for AbbVie, Novartis Pharmaceuticals Corporation, Pfizer, and Sanofi Genzyme/Regeneron. Address Correspondence to: Gurjit S. Kaeley, University of Florida College of Medicine, Division of Rheumatology, 653–1 West 8th St, LRC 2nd Floor L-14, Jacksonville, Florida 32209-6561, USA; E-mail: Gurjit.Kaeley@jax.ufl.edu
Phoebe Rich
Department of Medicine, University of Florida College of Medicine, Division of Rheumatology, 653–1 West 8th St, LRC 2nd Floor L-14, Jacksonville, Florida 32209- 6561, USA; University of Toronto, Women's College Research Institute, 76 Grenville Street Toronto, ON M5S 1B2, Canada; University of Ottawa, Faculty of Medicine, 1967 Riverside Drive, Ottawa, ON, K1H 7W9, Canada; Oregon Dermatology & Research Center, 2565 NW Lovejoy St # 200, Portland, OR 97210, USA; Salt Lake Clinic, 389 South 900 East, Salt Lake City, UT 84103, USA. This study is funded by Novartis Pharmaceuticals Corporation, East Hanover, NJ. G. S. Kaeley has received consultancy fees from Novartis Pharmaceuticals Corporation. L. Eder received research and educational grants or consultancy fees from AbbVie, Amgen, Pfizer, Janssen, Eli Lily, Novartis, and Celgene. S. Z. Aydin has received consultancy fees from AbbVie, Celgene, Eli Lily, Janssen, Novartis Pharmaceuticals Corporation Pfizer, and UCB. P. Rich has received research funding from AbbVie, Bristol-Myers-Squibb, Cellceutix (now Innovation Pharmaceuticals), Eli Lilly, Kadmon Holdings, Sun Pharma/Merck, and UCB. C. Bakewell has received consultancy fees from and/or served on speakers bureaus for AbbVie, Novartis Pharmaceuticals Corporation, Pfizer, and Sanofi Genzyme/Regeneron. Address Correspondence to: Gurjit S. Kaeley, University of Florida College of Medicine, Division of Rheumatology, 653–1 West 8th St, LRC 2nd Floor L-14, Jacksonville, Florida 32209-6561, USA; E-mail: Gurjit.Kaeley@jax.ufl.edu
Catherine J. Bakewell
Department of Medicine, University of Florida College of Medicine, Division of Rheumatology, 653–1 West 8th St, LRC 2nd Floor L-14, Jacksonville, Florida 32209- 6561, USA; University of Toronto, Women's College Research Institute, 76 Grenville Street Toronto, ON M5S 1B2, Canada; University of Ottawa, Faculty of Medicine, 1967 Riverside Drive, Ottawa, ON, K1H 7W9, Canada; Oregon Dermatology & Research Center, 2565 NW Lovejoy St # 200, Portland, OR 97210, USA; Salt Lake Clinic, 389 South 900 East, Salt Lake City, UT 84103, USA. This study is funded by Novartis Pharmaceuticals Corporation, East Hanover, NJ. G. S. Kaeley has received consultancy fees from Novartis Pharmaceuticals Corporation. L. Eder received research and educational grants or consultancy fees from AbbVie, Amgen, Pfizer, Janssen, Eli Lily, Novartis, and Celgene. S. Z. Aydin has received consultancy fees from AbbVie, Celgene, Eli Lily, Janssen, Novartis Pharmaceuticals Corporation Pfizer, and UCB. P. Rich has received research funding from AbbVie, Bristol-Myers-Squibb, Cellceutix (now Innovation Pharmaceuticals), Eli Lilly, Kadmon Holdings, Sun Pharma/Merck, and UCB. C. Bakewell has received consultancy fees from and/or served on speakers bureaus for AbbVie, Novartis Pharmaceuticals Corporation, Pfizer, and Sanofi Genzyme/Regeneron. Address Correspondence to: Gurjit S. Kaeley, University of Florida College of Medicine, Division of Rheumatology, 653–1 West 8th St, LRC 2nd Floor L-14, Jacksonville, Florida 32209-6561, USA; E-mail: Gurjit.Kaeley@jax.ufl.edu
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Accepted manuscript
Nail Psoriasis: Diagnosis, Assessment, Treatment Options, and Unmet Clinical Needs
Gurjit S. Kaeley, Lihi Eder, Sibel Zehra Aydin, Phoebe Rich, Catherine J. Bakewell
The Journal of Rheumatology Feb 2021, jrheum.201471; DOI: 10.3899/jrheum.201471